Tripeptide KdPT ameliorates intestinal inflammation in patients with mild to moderate active ulcerative colitis

被引：0
|
作者：
Kucharzik, T. [1 ]
Lemmnitz, G. [2 ]
Abels, C. [2 ]
Maaser, C. [1 ]
机构：
[1] Univ Gottingen, Luneburg Hosp, Dept Gen Med & Gastroenterol, Luneburg, Germany
[2] Wolff Pharma, Dermatol, Bielefeld, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60094-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP069
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] Tripeptide KDPT Accelerates Disease Remission in Patients With Mild to Moderate Active Ulcerative Colitis
    Kucharzik, Torsten
    Lemmnitz, Gunter
    Abels, Christoph
    Maaser, Christian
    GASTROENTEROLOGY, 2014, 146 (05) : S588 - S588
  • [2] The Tripeptide KdPT Protects from Intestinal Inflammation and Maintains Intestinal Barrier Function
    Bettenworth, Dominik
    Buyse, Marion
    Boehm, Markus
    Mennigen, Rudolf
    Czorniak, Isabel
    Kannengiesser, Klaus
    Brzoska, Thomas
    Luger, Thomas A.
    Kucharzik, Torsten
    Domschke, Wolfram
    Maaser, Christian
    Luegering, Andreas
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (03): : 1230 - 1242
  • [3] Dietary beta-fructans reduce inflammation in patients with mild to moderate Ulcerative Colitis
    Valcheva, Rosica
    Koleva, Petya
    Walter, Jens
    Ganzle, Michael
    Dieleman, Levinus
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S26 - S26
  • [4] The tripeptide KdPT ameliorates ongoing psoriasis-like skin inflammation in murine and human skin
    Mykicki, Nadine
    Klenner, Lars
    Baumann, Christoph
    Auriemma, Matteo
    Sternemann, Carlo
    Soeberdt, Michael
    Elliott, Graham R.
    Abels, Christoph
    Luger, Thomas A.
    Loser, Karin
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (04) : 328 - 334
  • [5] Mild-to-moderate ulcerative colitis
    Kruis, W.
    Bohm, S.
    Emerging Issues in Inflammatory Bowel Diseases, 2006, 151 : 169 - 173
  • [6] IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
    Sugimoto, Ken
    Ogawa, Atsuhiro
    Mizoguchi, Emiko
    Shimomura, Yasuyo
    Andoh, Akira
    Bhan, Atul K.
    Blumberg, Richard S.
    Xavier, Ramnik J.
    Mizoguchi, Atsushi
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (02): : 534 - 544
  • [7] Medication Preference of 400 patients with mild to moderate Ulcerative Colitis
    Mackenzie-Smith, L.
    Wuthrich, H.
    Laoun, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S521 - S522
  • [8] Management and treatment optimization of patients with mild to moderate ulcerative colitis
    D'Amico, Ferdinando
    Fasulo, Ernesto
    Jairath, Vipul
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 277 - 290
  • [9] Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis
    Ma, Christopher
    Sandborn, William J.
    D'Haens, Geert R.
    Zou, Guangyong
    Stitt, Larry W.
    Singh, Siddharth
    Ananthakrishnan, Ashwin N.
    Dulai, Parambir S.
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (08) : 1760 - +
  • [10] COLONOSCOPY WITHOUT PRIOR PREPARATION IN MILD TO MODERATE ACTIVE ULCERATIVE-COLITIS
    BAT, L
    PINES, A
    RON, E
    ROSENBLUM, Y
    LEVO, Y
    SHEMESH, E
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1991, 13 (01) : 46 - 48
12345